243 related articles for article (PubMed ID: 21715689)
1. Importance of the CCR5-CCL5 axis for mucosal Trypanosoma cruzi protection and B cell activation.
Sullivan NL; Eickhoff CS; Zhang X; Giddings OK; Lane TE; Hoft DF
J Immunol; 2011 Aug; 187(3):1358-68. PubMed ID: 21715689
[TBL] [Abstract][Full Text] [Related]
2. Th17 Cells Provide Mucosal Protection against Gastric Trypanosoma cruzi Infection.
Cai CW; Eickhoff CS; Meza KA; Blase JR; Audette RE; Chan DH; Bockerstett KA; DiPaolo RJ; Hoft DF
Infect Immun; 2021 Jun; 89(7):e0073820. PubMed ID: 33941576
[TBL] [Abstract][Full Text] [Related]
3. Deficiency of antigen-specific B cells results in decreased Trypanosoma cruzi systemic but not mucosal immunity due to CD8 T cell exhaustion.
Sullivan NL; Eickhoff CS; Sagartz J; Hoft DF
J Immunol; 2015 Feb; 194(4):1806-18. PubMed ID: 25595788
[TBL] [Abstract][Full Text] [Related]
4. The CC chemokine receptor 5 is important in control of parasite replication and acute cardiac inflammation following infection with Trypanosoma cruzi.
Hardison JL; Wrightsman RA; Carpenter PM; Kuziel WA; Lane TE; Manning JE
Infect Immun; 2006 Jan; 74(1):135-43. PubMed ID: 16368966
[TBL] [Abstract][Full Text] [Related]
5. Genetic Polymorphism at
Batista AM; Alvarado-Arnez LE; Alves SM; Melo G; Pereira IR; Ruivo LAS; da Silva AA; Gibaldi D; da Silva TDESP; de Lorena VMB; de Melo AS; de Araújo Soares AK; Barros MDS; Costa VMA; Cardoso CC; Pacheco AG; Carrazzone C; Oliveira W; Moraes MO; Lannes-Vieira J
Front Immunol; 2018; 9():615. PubMed ID: 29696014
[TBL] [Abstract][Full Text] [Related]
6. Type 1 immunity provides optimal protection against both mucosal and systemic Trypanosoma cruzi challenges.
Hoft DF; Eickhoff CS
Infect Immun; 2002 Dec; 70(12):6715-25. PubMed ID: 12438346
[TBL] [Abstract][Full Text] [Related]
7. CCR5 plays a critical role in the development of myocarditis and host protection in mice infected with Trypanosoma cruzi.
Machado FS; Koyama NS; Carregaro V; Ferreira BR; Milanezi CM; Teixeira MM; Rossi MA; Silva JS
J Infect Dis; 2005 Feb; 191(4):627-36. PubMed ID: 15655788
[TBL] [Abstract][Full Text] [Related]
8. Dogs infected with the blood trypomastigote form of Trypanosoma cruzi display an increase expression of cytokines and chemokines plus an intense cardiac parasitism during acute infection.
de Souza SM; Vieira PM; Roatt BM; Reis LE; da Silva Fonseca K; Nogueira NC; Reis AB; Tafuri WL; Carneiro CM
Mol Immunol; 2014 Mar; 58(1):92-7. PubMed ID: 24317279
[TBL] [Abstract][Full Text] [Related]
9. Specific humoral immunity versus polyclonal B cell activation in Trypanosoma cruzi infection of susceptible and resistant mice.
Bryan MA; Guyach SE; Norris KA
PLoS Negl Trop Dis; 2010 Jul; 4(7):e733. PubMed ID: 20625554
[TBL] [Abstract][Full Text] [Related]
10. Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming.
Hoft DF; Eickhoff CS; Giddings OK; Vasconcelos JR; Rodrigues MM
J Immunol; 2007 Nov; 179(10):6889-900. PubMed ID: 17982080
[TBL] [Abstract][Full Text] [Related]
11. Regulated on activation, normal T cell expressed and secreted (RANTES) antagonist (Met-RANTES) controls the early phase of Trypanosoma cruzi-elicited myocarditis.
Marino AP; da Silva A; dos Santos P; Pinto LM; Gazzinelli RT; Teixeira MM; Lannes-Vieira J
Circulation; 2004 Sep; 110(11):1443-9. PubMed ID: 15337689
[TBL] [Abstract][Full Text] [Related]
12. Gastric invasion by Trypanosoma cruzi and induction of protective mucosal immune responses.
Hoft DF; Farrar PL; Kratz-Owens K; Shaffer D
Infect Immun; 1996 Sep; 64(9):3800-10. PubMed ID: 8751932
[TBL] [Abstract][Full Text] [Related]
13. Involvement of CD4(+) Th1 cells in systemic immunity protective against primary and secondary challenges with Trypanosoma cruzi.
Hoft DF; Schnapp AR; Eickhoff CS; Roodman ST
Infect Immun; 2000 Jan; 68(1):197-204. PubMed ID: 10603388
[TBL] [Abstract][Full Text] [Related]
14. Intranasal vaccinations with the trans-sialidase antigen plus CpG Adjuvant induce mucosal immunity protective against conjunctival Trypanosoma cruzi challenges.
Giddings OK; Eickhoff CS; Sullivan NL; Hoft DF
Infect Immun; 2010 Mar; 78(3):1333-8. PubMed ID: 20048046
[TBL] [Abstract][Full Text] [Related]
15. Anatomical route of invasion and protective mucosal immunity in Trypanosoma cruzi conjunctival infection.
Giddings OK; Eickhoff CS; Smith TJ; Bryant LA; Hoft DF
Infect Immun; 2006 Oct; 74(10):5549-60. PubMed ID: 16988230
[TBL] [Abstract][Full Text] [Related]
16. Type 1 immunity provides both optimal mucosal and systemic protection against a mucosally invasive, intracellular pathogen.
Hoft DF; Eickhoff CS
Infect Immun; 2005 Aug; 73(8):4934-40. PubMed ID: 16041007
[TBL] [Abstract][Full Text] [Related]
17. Trypanosoma cruzi-triggered meningoencephalitis is a CCR1/CCR5-independent inflammatory process.
Silva AA; Roffê E; Santiago H; Marino AP; Kroll-Palhares K; Teixeira MM; Gazzinelli RT; Lannes-Vieira J
J Neuroimmunol; 2007 Mar; 184(1-2):156-63. PubMed ID: 17275101
[TBL] [Abstract][Full Text] [Related]
18. Induction of B- and T-cell responses to cruzipain in the murine model of Trypanosoma cruzi infection.
Schnapp AR; Eickhoff CS; Scharfstein J; Hoft DF
Microbes Infect; 2002 Jul; 4(8):805-13. PubMed ID: 12270727
[TBL] [Abstract][Full Text] [Related]
19. Trypanosoma cruzi antigen immunization induces a higher B cell survival in BALB/c mice, a susceptible strain, compared to C57BL/6 B lymphocytes, a resistant strain to cardiac autoimmunity.
Pellegrini A; Carrera-Silva EA; Arocena A; Cano RC; Aoki MP; Gea S
Med Microbiol Immunol; 2011 Nov; 200(4):209-18. PubMed ID: 21431877
[TBL] [Abstract][Full Text] [Related]
20. Timing of expression of inflammatory mediators in skeletal muscles from mice acutely infected with the RA strain of Trypanosoma cruzi.
Cutrullis RA; Postan M; Petray PB; Corral RS
Pathobiology; 2009; 76(4):170-80. PubMed ID: 19571606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
